Possible outcomes:
-Brookfield buys Asciano; QUB loses great opportunity, potentially faced with higher costs in some of its ancillary operations having a deflationery effect on earnings.
-QUB buys desired Asciano assets; massive earnings boost but also enormous gearing (to my knowledge), significant synergies and hugely earnings accretive despite the massive share dilution this move would require (which would probably more than double QUB's current market capital)
-ACCC prevents both QUB and Brookfield buying the company or certain assets; better than brookfield purchasing but not great for QUB, whose long term goal has been to acquire the Patrick assets.
- Forums
- ASX - By Stock
- Ann: Asciano grants Qube Consortium Due Diligence
Possible outcomes: -Brookfield buys Asciano; QUB loses great...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.98 |
Change
0.030(0.76%) |
Mkt cap ! $6.843B |
Open | High | Low | Value | Volume |
$4.00 | $4.04 | $3.98 | $10.24M | 2.568M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 197542 | $3.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.99 | 124007 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 49956 | 3.840 |
3 | 28469 | 3.830 |
5 | 57302 | 3.820 |
2 | 19923 | 3.810 |
3 | 6526 | 3.800 |
Price($) | Vol. | No. |
---|---|---|
3.860 | 35913 | 4 |
3.870 | 45168 | 2 |
3.880 | 14851 | 2 |
3.890 | 5558 | 1 |
3.900 | 36665 | 5 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
QUB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online